Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis

OBJECTIVE: To describe the pharmacodynamic monitoring of (immuno)proteasome inhibition following treatment with bortezomib in a therapy-refractory systemic lupus erythematosus (SLE) patient with life-threatening myocarditis and lupus nephritis. PATIENT AND METHODS: Inhibition of catalytic activities...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Lupus Sci Med
Glavni autori: de Groot, Karina A, Tsang a Sjoe, Michel, Niewerth, Denise, Cloos, Jacqueline, Blank, Jonathan L, Niessen, Hans W M, Zweegman, Sonja, Voskuyl, Alexandre E, Jansen, Gerrit, van der Heijden, Joost W
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2015
Teme:
Brief Communication
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4691954/
https://ncbi.nlm.nih.gov/pubmed/26719810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/lupus-2015-000121
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items